Financial Data and Key Metrics Changes - The company reported record fourth quarter total revenue of $92.9 million, representing a 23% increase year-over-year, exceeding guidance for the quarter [4][15] - Full year total revenue increased to $276.3 million, above the high end of guidance [15] - Gross margin for the fourth quarter was nearly 80%, with adjusted EBITDA margin at 40%, marking the highest quarterly margins to date [4][17] - Full year GAAP net income grew nearly 60% to $16.5 million, significantly outpacing revenue growth [18] Business Line Data and Key Metrics Changes - MACI generated record fourth quarter revenue of $84.1 million, a 23% increase year-over-year and 51% sequential growth from the third quarter [15][16] - Full year MACI revenue increased 21% to $239.5 million [15] - Burn care revenue for the fourth quarter was $8.8 million, exceeding guidance, with full year burn care revenue at $36.8 million [16][18] Market Data and Key Metrics Changes - MACI's leadership in the cartilage repair market has strengthened, with over 20,000 patients treated since its U.S. launch in 2017 [6] - The company achieved a prior authorization approval rate of over 95% for commercial patients in 2025, indicating strong market acceptance [7] Company Strategy and Development Direction - The company aims to capitalize on a larger MACI sales force to increase reach and penetration among existing surgeons [7][9] - Strategic initiatives include enhancing commercial analytics and standardizing best practices to drive deeper penetration within the surgeon user base [9] - The company initiated the phase 3 MACI Ankle MASCOT clinical study, targeting a market opportunity exceeding $1 billion [12] - Plans for U.K. expansion include submitting a marketing authorization application in mid-2026, with a potential launch in 2027 [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in entering 2026 with strong momentum, expecting total company revenue of approximately $316 million to $326 million [19][20] - MACI revenue guidance for 2026 is projected at $280 million to $286 million, reflecting continued growth trends [20] - The company anticipates a similar quarterly revenue mix for MACI as in the previous year, with expectations for sustained growth [20] Other Important Information - The company ended the year with approximately $200 million in cash and investments and no debt, enhancing its financial profile [4][19] - Operating cash flow for the full year was $52 million, indicating a positive cash generation trend [19] Q&A Session Summary Question: How do you think about the mix of price versus volume for MACI? - Management indicated that both price and volume are key growth drivers, with a significant improvement in MACI performance being volume-driven in the second half of the year [29] Question: Can you reflect on new doctor growth and existing sales dynamics? - Approximately two-thirds of trained surgeons are existing MACI users, with the remaining one-third being new or previously untrained surgeons [32] Question: Why is the 2026 MACI growth guidance slightly below previous expectations? - Management stated that the guidance reflects a prudent approach, with no material changes in expectations, and is consistent with prior commentary [38] Question: What are the expectations for the sales force expansion and free cash flow? - The sales force expansion is expected to enhance reach and productivity, while cash flow is anticipated to improve as the company enters a new phase of cash generation [53] Question: How is the company planning for the U.K. expansion? - The company plans to commercialize MACI in the U.K. independently, leveraging established approval and reimbursement pathways [79]

Financial Data and Key Metrics Changes - Bookings for Q4 2025 were $1.2 billion, growing approximately 3% year-over-year, with aftermarket bookings increasing 10% to $682 million [3][4] - Total revenues grew 4% year-over-year to $1.2 billion, with organic sales growth of roughly 1% and a 240 basis point benefit from foreign currency translation [7] - Adjusted gross margin reached 36%, a 320 basis point improvement versus last year, marking the 12th consecutive quarter of year-over-year margin expansion [8] - Adjusted EPS was $1.11, reflecting a 59% increase compared to the prior year [8] Business Line Data and Key Metrics Changes - FPD (Flowserve Pump Division) bookings grew 8%, with aftermarket growth of 12%, while original equipment bookings were up a modest 1% [9] - FCD (Flowserve Control Division) saw adjusted gross margin expand 220 basis points to 34%, and adjusted operating margin increased 440 basis points to 19.7% [10] - FCD bookings declined due to headwinds from project delays, with aftermarket bookings remaining roughly flat year-over-year [10] Market Data and Key Metrics Changes - The energy end-market showed robust maintenance activities, while the chemical sector represented the lowest growth end-market [19] - The general industries end-market benefited from sustained industrial expansion, particularly in mining, pharmaceuticals, and water, especially in North America and the Middle East [19] - The company anticipates mid-single-digit growth in bookings for 2026, assuming a generally consistent macroeconomic environment [21] Company Strategy and Development Direction - The company is focused on advancing its 3D Strategy to drive growth and leverage the Flowserve Business System for operational excellence [3][5] - Strategic acquisitions, including the recent agreement to acquire Trillium Valves, are aimed at enhancing the valve and actuation portfolio and expanding market reach in nuclear and traditional power sectors [18][21] - The company aims to maintain a disciplined approach to capital allocation, focusing on growth-enhancing opportunities while returning cash to shareholders [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strategic areas of focus to drive growth and deliver increasing shareholder value for years to come [5] - The company has built a more resilient supply chain, enabling quick responses to market shifts and macroeconomic changes [15] - Management highlighted the potential for nuclear energy to become an increasingly integral component of the business, with expectations for accelerated bookings growth [21][22] Other Important Information - The company returned $84 million in cash to shareholders in Q4 2025, including $57 million in share repurchases [11] - The balance sheet remains healthy, with net leverage of 1x, providing flexibility for capital allocation towards strategic growth opportunities [11] Q&A Session Summary Question: Organic revenue growth was light this quarter; can you provide context? - Management noted that about 50 basis points of revenue headwinds were due to delays in engineered projects, which are expected to resolve in the first half of 2026 [35][37] Question: What is the opportunity in Venezuela? - Management indicated that while Venezuela was once a significant market, they are prepared to support operations if investment resumes, but it is not included in the 2026 numbers [40][41] Question: Confidence in mid-single-digit order progression? - Management expressed confidence in mid-single-digit growth, driven by strong aftermarket performance and positive trends in the power end-market [45][48] Question: What are the implications of a shift towards gas turbines instead of nuclear? - Management believes nuclear will progress and emphasized their readiness to support traditional power growth if necessary [76][77] Question: How is the integration of MOGAS progressing? - Management reported successful integration of MOGAS, with significant margin improvements and a healthy project funnel for 2026 [84][86]

Financial Data and Key Metrics Changes - Total revenues for Q4 2025 grew 4% year-over-year to $1.2 billion, with organic sales growth of roughly 1% and a 240 basis point benefit from foreign currency translation [6][12] - Adjusted gross margin reached 36%, a 320 basis point improvement versus last year, marking the 12th consecutive quarter of year-over-year margin expansion [7] - Adjusted EPS was $1.11, a 59% increase compared to the prior year [8] Business Line Data and Key Metrics Changes - Aftermarket bookings grew 10% to $682 million, while original equipment revenues declined by 2% due to customer delays and material receipt timing [3][6] - FPD segment saw adjusted gross margin increase by 370 basis points to 37.1%, with bookings growing 8% [8][9] - FCD segment's adjusted gross margin expanded by 220 basis points to 34%, although bookings declined due to project delays [9][10] Market Data and Key Metrics Changes - The company reported $4.7 billion in total bookings for 2025, representing a 9% year-over-year growth, with a backlog of $2.9 billion at year-end [12][15] - The nuclear market contributed significantly, with $400 million in nuclear awards, highlighting strong market position [15][19] - General industries showed growth, particularly in North America and the Middle East, driven by sectors like mining and pharmaceuticals [19][62] Company Strategy and Development Direction - The company is focused on advancing its 3D Strategy to drive growth and enhance operational excellence through the Flowserve Business System [3][12] - Strategic acquisitions, including Trillium Valves, are aimed at expanding the valve and actuation portfolio and enhancing market reach in nuclear and traditional power sectors [18][20] - The company anticipates that nuclear energy will become increasingly integral to its business, with potential for accelerated bookings growth [20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strategic areas of focus to drive growth and deliver shareholder value, despite some short-term revenue headwinds [5][12] - The company expects mid-single-digit bookings growth in 2026, supported by a healthy backlog and positive trends in key markets [24][45] - Management highlighted the importance of operational excellence and the 80/20 program in driving margin improvements and simplifying operations [22][30] Other Important Information - The company returned $365 million to shareholders in 2025, including $255 million in share repurchases [11][27] - The balance sheet remains healthy with net leverage of one time, providing flexibility for capital allocation [11][27] - The company has a disciplined approach to capital allocation, focusing on growth-enhancing opportunities while maintaining an investment-grade rating [27][30] Q&A Session Summary Question: Organic revenue growth was light this quarter; can you provide context? - Management noted that about 50 basis points of revenue headwinds were due to delays in engineered projects, which are expected to resolve in the first half of 2026 [35][36] Question: What is the opportunity in Venezuela? - Management indicated that while Venezuela was previously a significant market, they are prepared to support operations if investment resumes, but it is not included in the 2026 numbers [39][40] Question: Confidence in mid-single-digit order progression? - Management expressed confidence in mid-single-digit growth, driven by strong aftermarket performance and positive trends in the power in-market [44][46] Question: What are the implications of the Trillium acquisition? - Management highlighted that Trillium's strong position in nuclear and traditional power markets aligns well with their growth strategy, and they expect to leverage operational excellence for cost synergies [50][52] Question: How does the backlog conversion impact EPS cadence? - Management stated that approximately 40% of EPS is expected in the first half of the year, with the first quarter typically being the lowest [63][64]

Financial Data and Key Metrics Changes - The company reported second quarter earnings with adjusted EPS of $0.91, reflecting a 25% increase year-over-year [9][19] - Full year adjusted EPS guidance was raised to $3.25 to $3.40, indicating a more than 25% year-over-year increase at the midpoint [8][29] - Revenue for the second quarter was $1,200,000,000, representing a 3% growth compared to the prior year [19][20] - Adjusted gross margins expanded by 260 basis points to 34.9%, while adjusted operating margins increased to 14.6% [9][21] Business Line Data and Key Metrics Changes - The Aftermarket business achieved bookings above $600,000,000 for the fifth consecutive quarter, with aftermarket revenues growing by 7% [10][19] - Original Equipment sales decreased by 2%, primarily due to lower engineered-to-order work [20] - FPD (Flowserve Pump Division) reported a 1% sales growth driven by aftermarket activity, with adjusted gross margins improving to 36.8% [23] - FCD (Flowserve Control Division) experienced a 2% growth in bookings and a 7% increase in sales, but margins were impacted by the Mogus acquisition [24][25] Market Data and Key Metrics Changes - Strong year-over-year growth of 9% was noted in general industries, while energy and chemical bookings decreased due to the non-recurrence of large projects [12] - The project funnel remains healthy, with a strong backlog of $2,900,000,000, providing certainty for future growth [14][15] - The macroeconomic environment has caused some project approvals to be delayed, particularly in the chemical and energy sectors [14][16] Company Strategy and Development Direction - The company remains committed to a disciplined approach to capital allocation, including potential share repurchases and M&A opportunities [6][64] - The Flowserve business system is being fully implemented across all business units, focusing on operational excellence and margin expansion [18][34] - The company is exploring partnerships, such as the MOU with Honeywell to integrate digital offerings, enhancing efficiency and creating recurring revenue streams [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a dynamic macro environment and maintain strong execution [7][34] - The company anticipates organic sales growth of 3% to 4% for the full year, slightly down from previous guidance [29] - Management highlighted the importance of maintaining a healthy balance sheet and investment-grade rating while pursuing growth opportunities [66] Other Important Information - The company received a $266,000,000 termination payment from the terminated merger with Chart Industries, which will be used for capital allocation [5][62] - The impact of tariffs is estimated to be neutral to earnings for the second quarter, with ongoing efforts to mitigate tariff effects [16][28] Q&A Session Summary Question: Can you provide more insight into the bookings environment and expectations for the book-to-bill ratio? - Management noted that the project spending was impacted by macroeconomic uncertainties, but the aftermarket business remained strong, with a book-to-bill ratio expected to be around 1.0 for the year [40][46] Question: How should we view the potential improvement in the FCD segment moving forward? - Management indicated that while FCD margins are currently below expectations, they are implementing the same operational excellence strategies that have benefited FPD, with confidence in future margin improvements [48][56] Question: What are the implications of the Chart merger experience on future growth ambitions? - Management emphasized that while disappointed with the merger outcome, they remain committed to pursuing M&A opportunities that align with their strategic goals [61][66] Question: Can you elaborate on the commercial excellence initiative and its deployment? - Management explained that the commercial excellence initiative aims to enhance commercial performance across the organization, focusing on growth and offsetting revenue reductions from the 8020 program [90][94]